Search

Author/Creator Lefkowitz, M P

1. Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials. (3rd October 2022)

Authors:
Adamson, C; Butt, J H; Rouleau, J; Abraham, W; Desai, A; Dickstein, K; Kober, L; Lefkowitz, M P; Packer, M; Petrie, M C; Swedberg, K; Solomon, S D; Zile, M; Jhund, P S; McMurray, J J V
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: insights from PARADIGM-HF. (3rd October 2022)

Authors:
Tolomeo, P; Kondo, T; Butt, J H; Desai, A S; Lefkowitz, M P; Rouleau, J L; Solomon, S D; Swedberg, K; Zile, M R; Campo, G; Jhund, P S; Packer, M; McMurray, J J V
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search